Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis

This retrospective cohort study aimed to analyze the clinical manifestations, complications, and maternal-fetal outcomes in patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery. The cohort included 61 pregnant women positive for SARS-CoV-2 infec...

Full description

Saved in:
Bibliographic Details
Published in:Journal of personalized medicine 2022-09, Vol.12 (9), p.1480
Main Authors: Grgić, Gordana, Cerovac, Anis, Hudić, Igor, Laganà, Antonio Simone, Favilli, Alessandro, Garzon, Simone, Chiantera, Vito, Margioula-Siarkou, Chrysoula, Hadžimehmedović, Azra, Mandžić, Amer
Format: Article
Language:English
Subjects:
Antibiotics
Apgar score
Birth weight
Cesarean section
Cohort analysis
Coronaviruses
COVID-19
Disease transmission
Ferritin
Fetuses
Fever
Hospitalization
Hypertension
Infections
Intensive care
Laboratories
Leukocytosis
Lymphopenia
Middle East respiratory syndrome
Neonates
Obstetrics
Patients
Physiology
Pneumonia
Precision medicine
Pregnancy
Premature birth
Respiratory diseases
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Viral infections
Viruses
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3
cites cdi_FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3
container_end_page
container_issue 9
container_start_page 1480
container_title Journal of personalized medicine
container_volume 12
creator Grgić, Gordana
Cerovac, Anis
Hudić, Igor
Laganà, Antonio Simone
Favilli, Alessandro
Garzon, Simone
Chiantera, Vito
Margioula-Siarkou, Chrysoula
Hadžimehmedović, Azra
Mandžić, Amer
description This retrospective cohort study aimed to analyze the clinical manifestations, complications, and maternal-fetal outcomes in patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery. The cohort included 61 pregnant women positive for SARS-CoV-2 infection at the time of delivery. Patients were divided into two groups: symptomatic and asymptomatic. We found a significantly higher rate of leukocytosis (p < 0.00078) and lymphopenia (p < 0.0024) in symptomatic women compared with asymptomatic ones. Other laboratory parameters, such as CRP (p = 0.002), AST (p = 0.007), LDH (p = 0.0142), ferritin (p = 0.0036), and D-dimer (p = 0.00124), were also significantly more often increased in the group of symptomatic pregnant women. Overall, symptomatic pregnant women with SARS-CoV-2 infection at the delivery show more often altered laboratory parameters compared with asymptomatic ones; nevertheless, they have a slightly higher but non-significant rate of preterm delivery, cesarean section, as well as lower neonatal birth weight and Apgar score, compared with asymptomatic women.
doi_str_mv 10.3390/jpm12091480
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9504598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2717690377</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3</originalsourceid><addsrcrecordid>eNpdkV1rFDEUhoMottReeS8BbwQZzedkxgthGa0WKiutH5chk0m6WWaSbZJZ2T_Q323q1rKam4Sch4dzzgvAc4zeUNqit-vNhAlqMWvQI3BMkOAVY6R-fPA-AqcprVE5DSekRk_BEa0xo6Rmx-C2G513Wo3wi_LOmpRVdsFD5Qe47FM2OToNl3PWYTIJOg-_RnPtlc_wZ_nx8JfLK3i1uLyquvCjIvDcW6P3igw_mNFtTdy9gwt4WVQhbe6KWwO7sAoxw4VX4y659Aw8sWpM5vT-PgHfzz5-6z5XF8tP593iotIMtbnCg-hJXw-K9r0SGhFqqWW8EchQLthgsLKEctooJQjqlR1oQwVvEeK8xY2lJ-D93ruZ-8kM2vgc1Sg30U0q7mRQTv5b8W4lr8NWthwx3jZF8OpeEMPNXNYlJ5e0GUflTZiTJAKLukVUiIK-_A9dhzmWgf9QNedUYFyo13tKl-2kaOxDMxjJu4jlQcSFfnHY_wP7N1D6G2fcomM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2716553711</pqid></control><display><type>article</type><title>Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Grgić, Gordana ; Cerovac, Anis ; Hudić, Igor ; Laganà, Antonio Simone ; Favilli, Alessandro ; Garzon, Simone ; Chiantera, Vito ; Margioula-Siarkou, Chrysoula ; Hadžimehmedović, Azra ; Mandžić, Amer</creator><creatorcontrib>Grgić, Gordana ; Cerovac, Anis ; Hudić, Igor ; Laganà, Antonio Simone ; Favilli, Alessandro ; Garzon, Simone ; Chiantera, Vito ; Margioula-Siarkou, Chrysoula ; Hadžimehmedović, Azra ; Mandžić, Amer</creatorcontrib><description>This retrospective cohort study aimed to analyze the clinical manifestations, complications, and maternal-fetal outcomes in patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery. The cohort included 61 pregnant women positive for SARS-CoV-2 infection at the time of delivery. Patients were divided into two groups: symptomatic and asymptomatic. We found a significantly higher rate of leukocytosis (p &lt; 0.00078) and lymphopenia (p &lt; 0.0024) in symptomatic women compared with asymptomatic ones. Other laboratory parameters, such as CRP (p = 0.002), AST (p = 0.007), LDH (p = 0.0142), ferritin (p = 0.0036), and D-dimer (p = 0.00124), were also significantly more often increased in the group of symptomatic pregnant women. Overall, symptomatic pregnant women with SARS-CoV-2 infection at the delivery show more often altered laboratory parameters compared with asymptomatic ones; nevertheless, they have a slightly higher but non-significant rate of preterm delivery, cesarean section, as well as lower neonatal birth weight and Apgar score, compared with asymptomatic women.</description><identifier>ISSN: 2075-4426</identifier><identifier>EISSN: 2075-4426</identifier><identifier>DOI: 10.3390/jpm12091480</identifier><identifier>PMID: 36143264</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibiotics ; Apgar score ; Birth weight ; Cesarean section ; Cohort analysis ; Coronaviruses ; COVID-19 ; Disease transmission ; Ferritin ; Fetuses ; Fever ; Hospitalization ; Hypertension ; Infections ; Intensive care ; Laboratories ; Leukocytosis ; Lymphopenia ; Middle East respiratory syndrome ; Neonates ; Obstetrics ; Patients ; Physiology ; Pneumonia ; Precision medicine ; Pregnancy ; Premature birth ; Respiratory diseases ; Severe acute respiratory syndrome coronavirus 2 ; Statistical analysis ; Viral infections ; Viruses ; Womens health</subject><ispartof>Journal of personalized medicine, 2022-09, Vol.12 (9), p.1480</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3</citedby><cites>FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3</cites><orcidid>0000-0002-6148-5043 ; 0000-0003-1543-2802 ; 0000-0002-5840-699X ; 0000-0002-1556-0962</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2716553711/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2716553711?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,38495,43874,44569,53769,53771,74158,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36143264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grgić, Gordana</creatorcontrib><creatorcontrib>Cerovac, Anis</creatorcontrib><creatorcontrib>Hudić, Igor</creatorcontrib><creatorcontrib>Laganà, Antonio Simone</creatorcontrib><creatorcontrib>Favilli, Alessandro</creatorcontrib><creatorcontrib>Garzon, Simone</creatorcontrib><creatorcontrib>Chiantera, Vito</creatorcontrib><creatorcontrib>Margioula-Siarkou, Chrysoula</creatorcontrib><creatorcontrib>Hadžimehmedović, Azra</creatorcontrib><creatorcontrib>Mandžić, Amer</creatorcontrib><title>Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis</title><title>Journal of personalized medicine</title><addtitle>J Pers Med</addtitle><description>This retrospective cohort study aimed to analyze the clinical manifestations, complications, and maternal-fetal outcomes in patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery. The cohort included 61 pregnant women positive for SARS-CoV-2 infection at the time of delivery. Patients were divided into two groups: symptomatic and asymptomatic. We found a significantly higher rate of leukocytosis (p &lt; 0.00078) and lymphopenia (p &lt; 0.0024) in symptomatic women compared with asymptomatic ones. Other laboratory parameters, such as CRP (p = 0.002), AST (p = 0.007), LDH (p = 0.0142), ferritin (p = 0.0036), and D-dimer (p = 0.00124), were also significantly more often increased in the group of symptomatic pregnant women. Overall, symptomatic pregnant women with SARS-CoV-2 infection at the delivery show more often altered laboratory parameters compared with asymptomatic ones; nevertheless, they have a slightly higher but non-significant rate of preterm delivery, cesarean section, as well as lower neonatal birth weight and Apgar score, compared with asymptomatic women.</description><subject>Antibiotics</subject><subject>Apgar score</subject><subject>Birth weight</subject><subject>Cesarean section</subject><subject>Cohort analysis</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease transmission</subject><subject>Ferritin</subject><subject>Fetuses</subject><subject>Fever</subject><subject>Hospitalization</subject><subject>Hypertension</subject><subject>Infections</subject><subject>Intensive care</subject><subject>Laboratories</subject><subject>Leukocytosis</subject><subject>Lymphopenia</subject><subject>Middle East respiratory syndrome</subject><subject>Neonates</subject><subject>Obstetrics</subject><subject>Patients</subject><subject>Physiology</subject><subject>Pneumonia</subject><subject>Precision medicine</subject><subject>Pregnancy</subject><subject>Premature birth</subject><subject>Respiratory diseases</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Statistical analysis</subject><subject>Viral infections</subject><subject>Viruses</subject><subject>Womens health</subject><issn>2075-4426</issn><issn>2075-4426</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNpdkV1rFDEUhoMottReeS8BbwQZzedkxgthGa0WKiutH5chk0m6WWaSbZJZ2T_Q323q1rKam4Sch4dzzgvAc4zeUNqit-vNhAlqMWvQI3BMkOAVY6R-fPA-AqcprVE5DSekRk_BEa0xo6Rmx-C2G513Wo3wi_LOmpRVdsFD5Qe47FM2OToNl3PWYTIJOg-_RnPtlc_wZ_nx8JfLK3i1uLyquvCjIvDcW6P3igw_mNFtTdy9gwt4WVQhbe6KWwO7sAoxw4VX4y659Aw8sWpM5vT-PgHfzz5-6z5XF8tP593iotIMtbnCg-hJXw-K9r0SGhFqqWW8EchQLthgsLKEctooJQjqlR1oQwVvEeK8xY2lJ-D93ruZ-8kM2vgc1Sg30U0q7mRQTv5b8W4lr8NWthwx3jZF8OpeEMPNXNYlJ5e0GUflTZiTJAKLukVUiIK-_A9dhzmWgf9QNedUYFyo13tKl-2kaOxDMxjJu4jlQcSFfnHY_wP7N1D6G2fcomM</recordid><startdate>20220909</startdate><enddate>20220909</enddate><creator>Grgić, Gordana</creator><creator>Cerovac, Anis</creator><creator>Hudić, Igor</creator><creator>Laganà, Antonio Simone</creator><creator>Favilli, Alessandro</creator><creator>Garzon, Simone</creator><creator>Chiantera, Vito</creator><creator>Margioula-Siarkou, Chrysoula</creator><creator>Hadžimehmedović, Azra</creator><creator>Mandžić, Amer</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6148-5043</orcidid><orcidid>https://orcid.org/0000-0003-1543-2802</orcidid><orcidid>https://orcid.org/0000-0002-5840-699X</orcidid><orcidid>https://orcid.org/0000-0002-1556-0962</orcidid></search><sort><creationdate>20220909</creationdate><title>Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis</title><author>Grgić, Gordana ; Cerovac, Anis ; Hudić, Igor ; Laganà, Antonio Simone ; Favilli, Alessandro ; Garzon, Simone ; Chiantera, Vito ; Margioula-Siarkou, Chrysoula ; Hadžimehmedović, Azra ; Mandžić, Amer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Apgar score</topic><topic>Birth weight</topic><topic>Cesarean section</topic><topic>Cohort analysis</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease transmission</topic><topic>Ferritin</topic><topic>Fetuses</topic><topic>Fever</topic><topic>Hospitalization</topic><topic>Hypertension</topic><topic>Infections</topic><topic>Intensive care</topic><topic>Laboratories</topic><topic>Leukocytosis</topic><topic>Lymphopenia</topic><topic>Middle East respiratory syndrome</topic><topic>Neonates</topic><topic>Obstetrics</topic><topic>Patients</topic><topic>Physiology</topic><topic>Pneumonia</topic><topic>Precision medicine</topic><topic>Pregnancy</topic><topic>Premature birth</topic><topic>Respiratory diseases</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Statistical analysis</topic><topic>Viral infections</topic><topic>Viruses</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grgić, Gordana</creatorcontrib><creatorcontrib>Cerovac, Anis</creatorcontrib><creatorcontrib>Hudić, Igor</creatorcontrib><creatorcontrib>Laganà, Antonio Simone</creatorcontrib><creatorcontrib>Favilli, Alessandro</creatorcontrib><creatorcontrib>Garzon, Simone</creatorcontrib><creatorcontrib>Chiantera, Vito</creatorcontrib><creatorcontrib>Margioula-Siarkou, Chrysoula</creatorcontrib><creatorcontrib>Hadžimehmedović, Azra</creatorcontrib><creatorcontrib>Mandžić, Amer</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of personalized medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grgić, Gordana</au><au>Cerovac, Anis</au><au>Hudić, Igor</au><au>Laganà, Antonio Simone</au><au>Favilli, Alessandro</au><au>Garzon, Simone</au><au>Chiantera, Vito</au><au>Margioula-Siarkou, Chrysoula</au><au>Hadžimehmedović, Azra</au><au>Mandžić, Amer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis</atitle><jtitle>Journal of personalized medicine</jtitle><addtitle>J Pers Med</addtitle><date>2022-09-09</date><risdate>2022</risdate><volume>12</volume><issue>9</issue><spage>1480</spage><pages>1480-</pages><issn>2075-4426</issn><eissn>2075-4426</eissn><abstract>This retrospective cohort study aimed to analyze the clinical manifestations, complications, and maternal-fetal outcomes in patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery. The cohort included 61 pregnant women positive for SARS-CoV-2 infection at the time of delivery. Patients were divided into two groups: symptomatic and asymptomatic. We found a significantly higher rate of leukocytosis (p &lt; 0.00078) and lymphopenia (p &lt; 0.0024) in symptomatic women compared with asymptomatic ones. Other laboratory parameters, such as CRP (p = 0.002), AST (p = 0.007), LDH (p = 0.0142), ferritin (p = 0.0036), and D-dimer (p = 0.00124), were also significantly more often increased in the group of symptomatic pregnant women. Overall, symptomatic pregnant women with SARS-CoV-2 infection at the delivery show more often altered laboratory parameters compared with asymptomatic ones; nevertheless, they have a slightly higher but non-significant rate of preterm delivery, cesarean section, as well as lower neonatal birth weight and Apgar score, compared with asymptomatic women.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36143264</pmid><doi>10.3390/jpm12091480</doi><orcidid>https://orcid.org/0000-0002-6148-5043</orcidid><orcidid>https://orcid.org/0000-0003-1543-2802</orcidid><orcidid>https://orcid.org/0000-0002-5840-699X</orcidid><orcidid>https://orcid.org/0000-0002-1556-0962</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2075-4426
ispartof Journal of personalized medicine, 2022-09, Vol.12 (9), p.1480
issn 2075-4426
2075-4426
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9504598
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Antibiotics
Apgar score
Birth weight
Cesarean section
Cohort analysis
Coronaviruses
COVID-19
Disease transmission
Ferritin
Fetuses
Fever
Hospitalization
Hypertension
Infections
Intensive care
Laboratories
Leukocytosis
Lymphopenia
Middle East respiratory syndrome
Neonates
Obstetrics
Patients
Physiology
Pneumonia
Precision medicine
Pregnancy
Premature birth
Respiratory diseases
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Viral infections
Viruses
Womens health
title Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T12%3A39%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Manifestation%20and%20Obstetric%20Outcomes%20in%20Pregnant%20Women%20with%20SARS-CoV-2%20Infection%20at%20Delivery:%20A%20Retrospective%20Cohort%20Analysis&rft.jtitle=Journal%20of%20personalized%20medicine&rft.au=Grgi%C4%87,%20Gordana&rft.date=2022-09-09&rft.volume=12&rft.issue=9&rft.spage=1480&rft.pages=1480-&rft.issn=2075-4426&rft.eissn=2075-4426&rft_id=info:doi/10.3390/jpm12091480&rft_dat=%3Cproquest_pubme%3E2717690377%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-1d7b2b6da3bba7c023f3f45870e3574de1af23538aa720bafd3837590055918f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2716553711&rft_id=info:pmid/36143264&rfr_iscdi=true